Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Ashland (ASH)
NYSE:ASH
Holding ASH?
Track your performance easily
Earnings Data
Report Date
Feb 04, 2025TBA Not Confirmed
Period Ending
2025 (Q1)Consensus EPS Forecast
$0.44Last Year’s EPS
$0.45Same Quarter Last Year
Strong Buy
Based on 9 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Nov 06, 2024
|% Change Since: -17.35%
|Next Earnings Date:Feb 04, 2025
Earnings Call Sentiment|Neutral
The earnings call presented a mixed outlook, with strong growth in adjusted EBITDA and successful portfolio optimization efforts. However, concerns about the Chinese market and operational challenges in Specialty Additives pose significant risks. Despite these challenges, Ashland remains focused on driving growth through strategic actions and innovation.Company Guidance
During Ashland's Q4 2024 earnings call, the company provided detailed guidance for fiscal 2025, projecting adjusted EBITDA in the range of $430 million to $470 million, with an anticipated sales figure between $1.9 billion and $2.05 billion. The guidance reflects mid-single-digit volume growth expectations while accounting for potential pricing pressures, particularly in China. Ashland plans to address $30 million in stranded costs resulting from portfolio optimization, with $15 million savings expected in fiscal 2025 and a significant ramp-up in fiscal 2026 and beyond. The company anticipates a challenging year ahead, with cautious views on the Chinese market, but remains committed to maintaining disciplined price-volume management and executing on restructuring and productivity initiatives to improve its competitive position.Strong Q4 Adjusted EBITDA Growth
Adjusted EBITDA for the quarter increased 68% to $124 million compared to the prior year.
Improved Gross Profit Margins
Gross profit margins increased 940 basis points to 34.3% in the quarter.
Successful Portfolio Optimization
Ashland completed the sale of the Nutraceuticals business and is progressing with the exit of the Avoca business to improve margins and reduce volatility.
Personal Care Segment Growth
Personal Care sales increased by 11% to $162 million with strong demand in skin and hair care, and adjusted EBITDA increased by 31%.
Life Sciences Segment Recovery
Life Sciences adjusted EBITDA increased by 17% due to higher production volumes and improved mix despite a 5% sales decline.
---
ASH Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
ASH Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Nov 06, 2024 | $86.93 | $80.28 | -7.65% |
| Aug 06, 2024 | $89.52 | $80.95 | -9.57% |
| Apr 30, 2024 | $94.02 | $93.21 | -0.86% |
| Jan 30, 2024 | $79.34 | $91.96 | +15.91% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Ashland (ASH) report earnings?
Ashland (ASH) is schdueled to report earning on Feb 04, 2025, TBA Not Confirmed.
What is Ashland (ASH) earnings time?
Ashland (ASH) earnings time is at Feb 04, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is ASH EPS forecast?
ASH EPS forecast for the fiscal quarter 2025 (Q1) is $0.44.
---
